Licensed Practical Nurse in Spencer, OH Accepting Medicare
3 Licensed Practical Nurse nurses found. Showing 1 - 3
 Anna M Mesia, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7188 Pawnee Rd, Spencer, OH 44275 Phone: 208-921-7279 |
Tessa Eileen Morrison, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 27750 West Rd, Spencer, OH 44275 Phone: 419-606-2596 |
Christine Ann Verescak, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 13166 New London Eastern Rd, Spencer, OH 44275 Phone: 330-648-3000 |
News Archive
MD Anderson researchers named Fellows to new AACR academy
Five researchers and leaders from The University of Texas MD Anderson Cancer Center have been named Fellows to a new academy launched by the world's oldest and largest organization dedicated to cancer research, the American Association for Cancer Research.
Researchers find that chance of collision decreased with more bicyclists
A University of Colorado Denver study examining collisions between bicycles and motorists, shows bicyclist safety significantly increases when there are more bikes on the road, a finding that could be attributed to a "safety in numbers effect."
Review describes new classes of drugs that target androgens in novel ways
Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects.
Laser Spine Institute acquires Aspen Back & Body
After helping thousands of patients get their lives back through minimally invasive endoscopic spinal surgery at facilities in Tampa and Scottsdale and soon Philadelphia, the Laser Spine Institute (LSI) announces their acquisition of Aspen Back & Body, LLC (ABB), extending LSI's patient care capabilities into non-surgical areas for the first time.
BIND Therapeutics and Pfizer sign collaboration agreement to develop, commercialize Accurins
BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins, announced today that it has entered into a global collaboration agreement with Pfizer Inc. to develop and commercialize Accurins utilizing select small molecule targeted therapies.
› Verified 6 days ago